Sign In
Buy EMBC
$3.13
+0.100 (+3.30%)
At Close: Jun 23, 2026
embecta to Participate in Investor Events
05:00pm, Thursday, 22'nd Aug 2024
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that manage
Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average
10:30am, Monday, 12'th Aug 2024
From a technical perspective, Embecta Corp. (EMBC) is looking like an interesting pick, as it just reached a key level of support. EMBC recently overtook the 200-day moving average, and this suggests
Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript
10:39am, Friday, 09'th Aug 2024
Embecta Corp. (NASDAQ:EMBC ) Q3 2024 Earnings Conference Call August 9, 2024 8:00 AM ET Company Participants Pravesh Khandelwal - VP & Head of IR Dev Kurdikar - President, CEO & Director Jake Elguicze
Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates
08:41am, Friday, 09'th Aug 2024
Embecta Corp. (EMBC) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.69 per share a year ago.
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
06:30am, Friday, 09'th Aug 2024
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and ni
embecta Announces Quarterly Cash Dividend
06:00am, Friday, 09'th Aug 2024
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
08:05am, Monday, 29'th Jul 2024
Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector NEW YORK , July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global p
embecta to Report Fiscal Third Quarter 2024 Financial Results
05:00pm, Thursday, 18'th Jul 2024
PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
07:30am, Thursday, 20'th Jun 2024
WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief Executi
Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs
04:30pm, Tuesday, 21'st May 2024
The White House recently confirmed increased tariffs on various Chinese goods. Investors and traders are on the lookout for stocks to benefit from China tariffs as the change could significantly impac
Embecta (EMBC) CEO on Diabetes Treatment Market
04:30pm, Friday, 17'th May 2024
Embecta (EMBC) CEO Dev Kurdikar joins Oliver Renick to give an overview of the company and discuss its 2Q earnings. He also talks about the impact of GLP-1 drugs.
Best Value Stocks to Buy for May 15th
08:45am, Wednesday, 15'th May 2024
CIXXF, JXN and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 15, 2024.
Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript
06:48pm, Saturday, 11'th May 2024
Embecta Corp. (NASDAQ:EMBC ) Q2 2024 Results Conference Call May 9, 2024 8:00 AM ET Company Participants Pravesh Khandelwal - Vice President & Head of Investor Relations Dev Kurdikar - President, Chie
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
06:30am, Thursday, 09'th May 2024
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six
